Pharming Shareholders approve items on EGM agenda
March 31, 2010 by biotechcheck.com · Leave a Comment
Pharming Shareholders approve items on EGM agenda
LEIDEN, NETHERLANDS–(Marketwire – 03/30/10) – Company to focus on transition to commercial phase Leiden, The Netherlands, March 30, 2010. Biotech company Pharming Group NV (”Pharming” or “the Company”) (NYSE Euronext: PHARM) announced today the increase of its authorized share capital to 400 million shares, adjusting the nominal value of the shares to EUR0.04 and the strengthening of its Board …
Read more on Marketwire via Yahoo! Finance
